Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
33,560
archived clinical trials in
Neurology

Bioequivalency Study of Oxcarbazepine 600 mg Tablets Under Fed Conditions
A Single Dose, 2-Period, 2-Treatment, 2-Way Crossover Bioequivalency Study of Oxcarbazepine 600 mg Tablets Under Fed Conditions
Status: Enrolling
Updated:  1/19/2018
Bio-Kinetics Clinical Applications, Inc .
mi
from
Springfield, MO
Bioequivalency Study of Oxcarbazepine 600 mg Tablets Under Fed Conditions
A Single Dose, 2-Period, 2-Treatment, 2-Way Crossover Bioequivalency Study of Oxcarbazepine 600 mg Tablets Under Fed Conditions
Status: Enrolling
Updated: 1/19/2018
Bio-Kinetics Clinical Applications, Inc .
mi
from
Springfield, MO
Click here to add this to my saved trials
Bioequivalency Study of Levetiracetam 1g Under Fasted Conditions
A Single Dose, 2-Period, 2-Treatment, 2-Way Crossover Bioequivalency Study of Levetiracetam 1g Tablets Under Fasting Conditions
Status: Enrolling
Updated:  1/19/2018
Novum Pharmaceutical Research Services
mi
from
Houston, TX
Bioequivalency Study of Levetiracetam 1g Under Fasted Conditions
A Single Dose, 2-Period, 2-Treatment, 2-Way Crossover Bioequivalency Study of Levetiracetam 1g Tablets Under Fasting Conditions
Status: Enrolling
Updated: 1/19/2018
Novum Pharmaceutical Research Services
mi
from
Houston, TX
Click here to add this to my saved trials
Bioequivalency Study of Levetiracetam 750 mg Tablets Under Fed Conditions
A Single Dose, 2-Period, 2-Treatment, 2-Way Crossover Bioequivalency Study of Levetiracetam 750 mg Tablets Under Fed Conditions
Status: Enrolling
Updated:  1/19/2018
MDS Pharma Services
mi
from
Phoenix, AZ
Bioequivalency Study of Levetiracetam 750 mg Tablets Under Fed Conditions
A Single Dose, 2-Period, 2-Treatment, 2-Way Crossover Bioequivalency Study of Levetiracetam 750 mg Tablets Under Fed Conditions
Status: Enrolling
Updated: 1/19/2018
MDS Pharma Services
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Bioequivalency Study of Levetiracetam 750 mg Tablets Under Fasting Conditions
A Single Dose, 2-Period, 2-Treatment, 2-Way Crossover Bioequivalency Study of Levetiracetam 750 mg Tablets Under Fasting Conditions
Status: Enrolling
Updated:  1/19/2018
MDS Pharma Services
mi
from
Phoenix, AZ
Bioequivalency Study of Levetiracetam 750 mg Tablets Under Fasting Conditions
A Single Dose, 2-Period, 2-Treatment, 2-Way Crossover Bioequivalency Study of Levetiracetam 750 mg Tablets Under Fasting Conditions
Status: Enrolling
Updated: 1/19/2018
MDS Pharma Services
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Bioequivalency Study of Levetiracetam 1g Tablets Under Fed Conditions
A Single Dose, 2-Period, 2-Treatment, 2-Way Crossover Bioequivalency Study of Levetiracetam 1g Tablets Under Fed Conditions
Status: Enrolling
Updated:  1/19/2018
Novum Pharmaceutical Research Services
mi
from
Houston, TX
Bioequivalency Study of Levetiracetam 1g Tablets Under Fed Conditions
A Single Dose, 2-Period, 2-Treatment, 2-Way Crossover Bioequivalency Study of Levetiracetam 1g Tablets Under Fed Conditions
Status: Enrolling
Updated: 1/19/2018
Novum Pharmaceutical Research Services
mi
from
Houston, TX
Click here to add this to my saved trials
Crossover Bioequivalence Study of Oxcarbazepine 600 mg Suspension Under Fasted Conditions
A Single Dose, Two-Period, Two-Treatment, Two-Sequence Crossover Bioequivalence Study of Oxcarbazepine 600 mg Suspension Under Fasted Conditions
Status: Enrolling
Updated:  1/19/2018
Worldwide Clinical Trials Drug Development Solutions (formerly CEDRA Clinical Research)
mi
from
San Antonio, TX
Crossover Bioequivalence Study of Oxcarbazepine 600 mg Suspension Under Fasted Conditions
A Single Dose, Two-Period, Two-Treatment, Two-Sequence Crossover Bioequivalence Study of Oxcarbazepine 600 mg Suspension Under Fasted Conditions
Status: Enrolling
Updated: 1/19/2018
Worldwide Clinical Trials Drug Development Solutions (formerly CEDRA Clinical Research)
mi
from
San Antonio, TX
Click here to add this to my saved trials
Crossover Bioequivalence Study of Oxcarbazepine 600 mg Suspension Under Fed Conditions
A Single Dose, Two-Period, Two-Treatment, Two-Sequence Crossover Bioequivalence Study of Oxcarbazepine 600 mg Suspension Under Fed Conditions
Status: Enrolling
Updated:  1/19/2018
Worldwide Clinical Trials Drug Development Solutions (formerly CEDRA Clinical Research)
mi
from
San Antonio, TX
Crossover Bioequivalence Study of Oxcarbazepine 600 mg Suspension Under Fed Conditions
A Single Dose, Two-Period, Two-Treatment, Two-Sequence Crossover Bioequivalence Study of Oxcarbazepine 600 mg Suspension Under Fed Conditions
Status: Enrolling
Updated: 1/19/2018
Worldwide Clinical Trials Drug Development Solutions (formerly CEDRA Clinical Research)
mi
from
San Antonio, TX
Click here to add this to my saved trials
Rapalogues for Autism Phenotype in TSC: A Feasibility Study
Rapalogues for Autism Phenotype in TSC: A Feasibility Study
Status: Enrolling
Updated:  1/21/2018
Kennedy Krieger Institute
mi
from
Baltimore, MD
Rapalogues for Autism Phenotype in TSC: A Feasibility Study
Rapalogues for Autism Phenotype in TSC: A Feasibility Study
Status: Enrolling
Updated: 1/21/2018
Kennedy Krieger Institute
mi
from
Baltimore, MD
Click here to add this to my saved trials
Enhancement of Functional Recovery After Peripheral Nerve Injury With Tacrolimus
Enhancement of Functional Recovery After Peripheral Nerve Injury With Tacrolimus
Status: Enrolling
Updated:  1/22/2018
Washington University School of Medicine
mi
from
Saint Louis, MO
Enhancement of Functional Recovery After Peripheral Nerve Injury With Tacrolimus
Enhancement of Functional Recovery After Peripheral Nerve Injury With Tacrolimus
Status: Enrolling
Updated: 1/22/2018
Washington University School of Medicine
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Dose Escalation Study of OMP-54F28 in Combination With Paclitaxel and Carboplatin in Patients With Recurrent Platinum-Sensitive Ovarian Cancer
A Phase 1b Dose Escalation Study of OMP-54F28 in Combination With Paclitaxel and Carboplatin in Patients With Recurrent Platinum-Sensitive Ovarian Cancer
Status: Enrolling
Updated:  1/22/2018
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Dose Escalation Study of OMP-54F28 in Combination With Paclitaxel and Carboplatin in Patients With Recurrent Platinum-Sensitive Ovarian Cancer
A Phase 1b Dose Escalation Study of OMP-54F28 in Combination With Paclitaxel and Carboplatin in Patients With Recurrent Platinum-Sensitive Ovarian Cancer
Status: Enrolling
Updated: 1/22/2018
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Dose Escalation Study of OMP-54F28 in Combination With Paclitaxel and Carboplatin in Patients With Recurrent Platinum-Sensitive Ovarian Cancer
A Phase 1b Dose Escalation Study of OMP-54F28 in Combination With Paclitaxel and Carboplatin in Patients With Recurrent Platinum-Sensitive Ovarian Cancer
Status: Enrolling
Updated:  1/22/2018
OU Medical Center Laboratory
mi
from
Oklahoma City, OK
Dose Escalation Study of OMP-54F28 in Combination With Paclitaxel and Carboplatin in Patients With Recurrent Platinum-Sensitive Ovarian Cancer
A Phase 1b Dose Escalation Study of OMP-54F28 in Combination With Paclitaxel and Carboplatin in Patients With Recurrent Platinum-Sensitive Ovarian Cancer
Status: Enrolling
Updated: 1/22/2018
OU Medical Center Laboratory
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Dose Escalation Study of OMP-54F28 in Combination With Paclitaxel and Carboplatin in Patients With Recurrent Platinum-Sensitive Ovarian Cancer
A Phase 1b Dose Escalation Study of OMP-54F28 in Combination With Paclitaxel and Carboplatin in Patients With Recurrent Platinum-Sensitive Ovarian Cancer
Status: Enrolling
Updated:  1/22/2018
Fox Chase Cancer Center
mi
from
Philadelphia, PA
Dose Escalation Study of OMP-54F28 in Combination With Paclitaxel and Carboplatin in Patients With Recurrent Platinum-Sensitive Ovarian Cancer
A Phase 1b Dose Escalation Study of OMP-54F28 in Combination With Paclitaxel and Carboplatin in Patients With Recurrent Platinum-Sensitive Ovarian Cancer
Status: Enrolling
Updated: 1/22/2018
Fox Chase Cancer Center
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Dose Escalation Study of OMP-54F28 in Combination With Paclitaxel and Carboplatin in Patients With Recurrent Platinum-Sensitive Ovarian Cancer
A Phase 1b Dose Escalation Study of OMP-54F28 in Combination With Paclitaxel and Carboplatin in Patients With Recurrent Platinum-Sensitive Ovarian Cancer
Status: Enrolling
Updated:  1/22/2018
University of Pennsylvania Health System
mi
from
Philadelphia, PA
Dose Escalation Study of OMP-54F28 in Combination With Paclitaxel and Carboplatin in Patients With Recurrent Platinum-Sensitive Ovarian Cancer
A Phase 1b Dose Escalation Study of OMP-54F28 in Combination With Paclitaxel and Carboplatin in Patients With Recurrent Platinum-Sensitive Ovarian Cancer
Status: Enrolling
Updated: 1/22/2018
University of Pennsylvania Health System
mi
from
Philadelphia, PA
Click here to add this to my saved trials
An Open Pilot Trial of BHV-4157
An Open Pilot Trial of BHV-4157 in Adult Subjects With Cerebellar Ataxia
Status: Enrolling
Updated:  1/22/2018
University of California at Los Angeles
mi
from
Los Angeles, CA
An Open Pilot Trial of BHV-4157
An Open Pilot Trial of BHV-4157 in Adult Subjects With Cerebellar Ataxia
Status: Enrolling
Updated: 1/22/2018
University of California at Los Angeles
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Imaging of Traumatic Brain Injury
Prognostic Value of MR Imaging Markers in the Assessment of Traumatic Brain Injury Patients
Status: Enrolling
Updated:  1/23/2018
University of Maryland Medical Center
mi
from
Baltimore, MD
Imaging of Traumatic Brain Injury
Prognostic Value of MR Imaging Markers in the Assessment of Traumatic Brain Injury Patients
Status: Enrolling
Updated: 1/23/2018
University of Maryland Medical Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
Caprylic Triglyceride for Treatment of Cognitive Impairments in Multiple Sclerosis
A Randomized Double-Blind Placebo-Controlled Study of Caprylic Triglyceride for Cognitive Impairment in Subjects With Multiple Sclerosis.
Status: Enrolling
Updated:  1/23/2018
University of Miami Miller School of Medicine
mi
from
Miami, FL
Caprylic Triglyceride for Treatment of Cognitive Impairments in Multiple Sclerosis
A Randomized Double-Blind Placebo-Controlled Study of Caprylic Triglyceride for Cognitive Impairment in Subjects With Multiple Sclerosis.
Status: Enrolling
Updated: 1/23/2018
University of Miami Miller School of Medicine
mi
from
Miami, FL
Click here to add this to my saved trials
Effects of Liraglutide on Hippocampal Structure and Function in Aging Adults With Prediabetes
Effects of Liraglutide on Hippocampal Structure and Function in Aging Adults With Prediabetes
Status: Enrolling
Updated:  1/23/2018
Stanford Department of Psychiatry
mi
from
Stanford, CA
Effects of Liraglutide on Hippocampal Structure and Function in Aging Adults With Prediabetes
Effects of Liraglutide on Hippocampal Structure and Function in Aging Adults With Prediabetes
Status: Enrolling
Updated: 1/23/2018
Stanford Department of Psychiatry
mi
from
Stanford, CA
Click here to add this to my saved trials
Repetitive Transcranial Magnetic Stimulation for Apathy in Alzheimer's Dementia
Repetitive Transcranial Magnetic Stimulation for Apathy in Alzheimer's Dementia
Status: Enrolling
Updated:  1/23/2018
Central Arkansas Veterans Healthcare System
mi
from
Little Rock, AR
Repetitive Transcranial Magnetic Stimulation for Apathy in Alzheimer's Dementia
Repetitive Transcranial Magnetic Stimulation for Apathy in Alzheimer's Dementia
Status: Enrolling
Updated: 1/23/2018
Central Arkansas Veterans Healthcare System
mi
from
Little Rock, AR
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of Nusinersen (ISIS 396443) in Participants With Later-onset Spinal Muscular Atrophy (SMA)
A Phase 3, Randomized, Double-blind, Sham-Procedure Controlled Study to Assess the Clinical Efficacy and Safety of ISIS 396443 Administered Intrathecally in Patients With Later-onset Spinal Muscular Atrophy
Status: Enrolling
Updated:  1/23/2018
Children's Hospital Colorado
mi
from
Aurora, CO
A Study to Assess the Efficacy and Safety of Nusinersen (ISIS 396443) in Participants With Later-onset Spinal Muscular Atrophy (SMA)
A Phase 3, Randomized, Double-blind, Sham-Procedure Controlled Study to Assess the Clinical Efficacy and Safety of ISIS 396443 Administered Intrathecally in Patients With Later-onset Spinal Muscular Atrophy
Status: Enrolling
Updated: 1/23/2018
Children's Hospital Colorado
mi
from
Aurora, CO
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of Nusinersen (ISIS 396443) in Participants With Later-onset Spinal Muscular Atrophy (SMA)
A Phase 3, Randomized, Double-blind, Sham-Procedure Controlled Study to Assess the Clinical Efficacy and Safety of ISIS 396443 Administered Intrathecally in Patients With Later-onset Spinal Muscular Atrophy
Status: Enrolling
Updated:  1/23/2018
Nemours Children's Hospital
mi
from
Orlando, FL
A Study to Assess the Efficacy and Safety of Nusinersen (ISIS 396443) in Participants With Later-onset Spinal Muscular Atrophy (SMA)
A Phase 3, Randomized, Double-blind, Sham-Procedure Controlled Study to Assess the Clinical Efficacy and Safety of ISIS 396443 Administered Intrathecally in Patients With Later-onset Spinal Muscular Atrophy
Status: Enrolling
Updated: 1/23/2018
Nemours Children's Hospital
mi
from
Orlando, FL
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of Nusinersen (ISIS 396443) in Participants With Later-onset Spinal Muscular Atrophy (SMA)
A Phase 3, Randomized, Double-blind, Sham-Procedure Controlled Study to Assess the Clinical Efficacy and Safety of ISIS 396443 Administered Intrathecally in Patients With Later-onset Spinal Muscular Atrophy
Status: Enrolling
Updated:  1/23/2018
Ann & Robert H. Lurie Children's Hospital of Chicago
mi
from
Chicago, IL
A Study to Assess the Efficacy and Safety of Nusinersen (ISIS 396443) in Participants With Later-onset Spinal Muscular Atrophy (SMA)
A Phase 3, Randomized, Double-blind, Sham-Procedure Controlled Study to Assess the Clinical Efficacy and Safety of ISIS 396443 Administered Intrathecally in Patients With Later-onset Spinal Muscular Atrophy
Status: Enrolling
Updated: 1/23/2018
Ann & Robert H. Lurie Children's Hospital of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of Nusinersen (ISIS 396443) in Participants With Later-onset Spinal Muscular Atrophy (SMA)
A Phase 3, Randomized, Double-blind, Sham-Procedure Controlled Study to Assess the Clinical Efficacy and Safety of ISIS 396443 Administered Intrathecally in Patients With Later-onset Spinal Muscular Atrophy
Status: Enrolling
Updated:  1/23/2018
Boston Children's Hospital
mi
from
Boston, MA
A Study to Assess the Efficacy and Safety of Nusinersen (ISIS 396443) in Participants With Later-onset Spinal Muscular Atrophy (SMA)
A Phase 3, Randomized, Double-blind, Sham-Procedure Controlled Study to Assess the Clinical Efficacy and Safety of ISIS 396443 Administered Intrathecally in Patients With Later-onset Spinal Muscular Atrophy
Status: Enrolling
Updated: 1/23/2018
Boston Children's Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of Nusinersen (ISIS 396443) in Participants With Later-onset Spinal Muscular Atrophy (SMA)
A Phase 3, Randomized, Double-blind, Sham-Procedure Controlled Study to Assess the Clinical Efficacy and Safety of ISIS 396443 Administered Intrathecally in Patients With Later-onset Spinal Muscular Atrophy
Status: Enrolling
Updated:  1/23/2018
Columbia University Medical Center
mi
from
New York, NY
A Study to Assess the Efficacy and Safety of Nusinersen (ISIS 396443) in Participants With Later-onset Spinal Muscular Atrophy (SMA)
A Phase 3, Randomized, Double-blind, Sham-Procedure Controlled Study to Assess the Clinical Efficacy and Safety of ISIS 396443 Administered Intrathecally in Patients With Later-onset Spinal Muscular Atrophy
Status: Enrolling
Updated: 1/23/2018
Columbia University Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of Nusinersen (ISIS 396443) in Participants With Later-onset Spinal Muscular Atrophy (SMA)
A Phase 3, Randomized, Double-blind, Sham-Procedure Controlled Study to Assess the Clinical Efficacy and Safety of ISIS 396443 Administered Intrathecally in Patients With Later-onset Spinal Muscular Atrophy
Status: Enrolling
Updated:  1/23/2018
Children's Hospital of Philadelphia - Neurology
mi
from
Philadelphia, PA
A Study to Assess the Efficacy and Safety of Nusinersen (ISIS 396443) in Participants With Later-onset Spinal Muscular Atrophy (SMA)
A Phase 3, Randomized, Double-blind, Sham-Procedure Controlled Study to Assess the Clinical Efficacy and Safety of ISIS 396443 Administered Intrathecally in Patients With Later-onset Spinal Muscular Atrophy
Status: Enrolling
Updated: 1/23/2018
Children's Hospital of Philadelphia - Neurology
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of Nusinersen (ISIS 396443) in Participants With Later-onset Spinal Muscular Atrophy (SMA)
A Phase 3, Randomized, Double-blind, Sham-Procedure Controlled Study to Assess the Clinical Efficacy and Safety of ISIS 396443 Administered Intrathecally in Patients With Later-onset Spinal Muscular Atrophy
Status: Enrolling
Updated:  1/23/2018
UCLA Clinical & Translational Research Center
mi
from
Los Angeles, CA
A Study to Assess the Efficacy and Safety of Nusinersen (ISIS 396443) in Participants With Later-onset Spinal Muscular Atrophy (SMA)
A Phase 3, Randomized, Double-blind, Sham-Procedure Controlled Study to Assess the Clinical Efficacy and Safety of ISIS 396443 Administered Intrathecally in Patients With Later-onset Spinal Muscular Atrophy
Status: Enrolling
Updated: 1/23/2018
UCLA Clinical & Translational Research Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of Nusinersen (ISIS 396443) in Participants With Later-onset Spinal Muscular Atrophy (SMA)
A Phase 3, Randomized, Double-blind, Sham-Procedure Controlled Study to Assess the Clinical Efficacy and Safety of ISIS 396443 Administered Intrathecally in Patients With Later-onset Spinal Muscular Atrophy
Status: Enrolling
Updated:  1/23/2018
Lucile Packard Children's Hospital at Stanford
mi
from
Palo Alto, CA
A Study to Assess the Efficacy and Safety of Nusinersen (ISIS 396443) in Participants With Later-onset Spinal Muscular Atrophy (SMA)
A Phase 3, Randomized, Double-blind, Sham-Procedure Controlled Study to Assess the Clinical Efficacy and Safety of ISIS 396443 Administered Intrathecally in Patients With Later-onset Spinal Muscular Atrophy
Status: Enrolling
Updated: 1/23/2018
Lucile Packard Children's Hospital at Stanford
mi
from
Palo Alto, CA
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of Nusinersen (ISIS 396443) in Participants With Later-onset Spinal Muscular Atrophy (SMA)
A Phase 3, Randomized, Double-blind, Sham-Procedure Controlled Study to Assess the Clinical Efficacy and Safety of ISIS 396443 Administered Intrathecally in Patients With Later-onset Spinal Muscular Atrophy
Status: Enrolling
Updated:  1/23/2018
Washington University School of Medicine
mi
from
Saint Louis, MO
A Study to Assess the Efficacy and Safety of Nusinersen (ISIS 396443) in Participants With Later-onset Spinal Muscular Atrophy (SMA)
A Phase 3, Randomized, Double-blind, Sham-Procedure Controlled Study to Assess the Clinical Efficacy and Safety of ISIS 396443 Administered Intrathecally in Patients With Later-onset Spinal Muscular Atrophy
Status: Enrolling
Updated: 1/23/2018
Washington University School of Medicine
mi
from
Saint Louis, MO
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of Nusinersen (ISIS 396443) in Participants With Later-onset Spinal Muscular Atrophy (SMA)
A Phase 3, Randomized, Double-blind, Sham-Procedure Controlled Study to Assess the Clinical Efficacy and Safety of ISIS 396443 Administered Intrathecally in Patients With Later-onset Spinal Muscular Atrophy
Status: Enrolling
Updated:  1/23/2018
Oregon Health and Science University
mi
from
Portland, OR
A Study to Assess the Efficacy and Safety of Nusinersen (ISIS 396443) in Participants With Later-onset Spinal Muscular Atrophy (SMA)
A Phase 3, Randomized, Double-blind, Sham-Procedure Controlled Study to Assess the Clinical Efficacy and Safety of ISIS 396443 Administered Intrathecally in Patients With Later-onset Spinal Muscular Atrophy
Status: Enrolling
Updated: 1/23/2018
Oregon Health and Science University
mi
from
Portland, OR
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of Nusinersen (ISIS 396443) in Participants With Later-onset Spinal Muscular Atrophy (SMA)
A Phase 3, Randomized, Double-blind, Sham-Procedure Controlled Study to Assess the Clinical Efficacy and Safety of ISIS 396443 Administered Intrathecally in Patients With Later-onset Spinal Muscular Atrophy
Status: Enrolling
Updated:  1/23/2018
Children's Medical Center
mi
from
Dallas, TX
A Study to Assess the Efficacy and Safety of Nusinersen (ISIS 396443) in Participants With Later-onset Spinal Muscular Atrophy (SMA)
A Phase 3, Randomized, Double-blind, Sham-Procedure Controlled Study to Assess the Clinical Efficacy and Safety of ISIS 396443 Administered Intrathecally in Patients With Later-onset Spinal Muscular Atrophy
Status: Enrolling
Updated: 1/23/2018
Children's Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of Nusinersen (ISIS 396443) in Participants With Later-onset Spinal Muscular Atrophy (SMA)
A Phase 3, Randomized, Double-blind, Sham-Procedure Controlled Study to Assess the Clinical Efficacy and Safety of ISIS 396443 Administered Intrathecally in Patients With Later-onset Spinal Muscular Atrophy
Status: Enrolling
Updated:  1/23/2018
Children's Hospital - London Health Sciences Centre
mi
from
London,
A Study to Assess the Efficacy and Safety of Nusinersen (ISIS 396443) in Participants With Later-onset Spinal Muscular Atrophy (SMA)
A Phase 3, Randomized, Double-blind, Sham-Procedure Controlled Study to Assess the Clinical Efficacy and Safety of ISIS 396443 Administered Intrathecally in Patients With Later-onset Spinal Muscular Atrophy
Status: Enrolling
Updated: 1/23/2018
Children's Hospital - London Health Sciences Centre
mi
from
London,
Click here to add this to my saved trials
Characterizing Hemodynamic Compensation in Patients With Intracranial Stenosis
Vanderbilt Assessment of Multi-modal MRI in Patients At-Risk for Stroke With Intracranial Stenosis
Status: Enrolling
Updated:  1/23/2018
Vanderbilt University Medical Center
mi
from
Nashville, TN
Characterizing Hemodynamic Compensation in Patients With Intracranial Stenosis
Vanderbilt Assessment of Multi-modal MRI in Patients At-Risk for Stroke With Intracranial Stenosis
Status: Enrolling
Updated: 1/23/2018
Vanderbilt University Medical Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Genetic Characterization of Individuals With Limb Girdle Muscular Dystrophy
Genetic Characterization of Individuals With Limb Girdle Muscular Dystrophy
Status: Enrolling
Updated:  1/23/2018
Nationwide Children's Hospital
mi
from
Columbus, OH
Genetic Characterization of Individuals With Limb Girdle Muscular Dystrophy
Genetic Characterization of Individuals With Limb Girdle Muscular Dystrophy
Status: Enrolling
Updated: 1/23/2018
Nationwide Children's Hospital
mi
from
Columbus, OH
Click here to add this to my saved trials
Reducing Assymmetry During Gait Using the TPAD (Tethered Pelvic Assist Device) for Stroke Patients
The Integration of Motor Learning Principles to Reduce Load Asymmetry Using a Novel Robotic Device in Individuals Chronically Post-Stroke
Status: Enrolling
Updated:  1/23/2018
Columbia University Medical Center
mi
from
New York, NY
Reducing Assymmetry During Gait Using the TPAD (Tethered Pelvic Assist Device) for Stroke Patients
The Integration of Motor Learning Principles to Reduce Load Asymmetry Using a Novel Robotic Device in Individuals Chronically Post-Stroke
Status: Enrolling
Updated: 1/23/2018
Columbia University Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
A Study to Test the SENSE Device in Patients With Intracranial Hemorrhage
An Early Feasibility Study to Evaluate the User Interfaces and Sensitivity of the SENSE Device in Patients With Intracranial Hemorrhage
Status: Enrolling
Updated:  1/23/2018
University of Cincinnati Medical Center
mi
from
Cincinnati, OH
A Study to Test the SENSE Device in Patients With Intracranial Hemorrhage
An Early Feasibility Study to Evaluate the User Interfaces and Sensitivity of the SENSE Device in Patients With Intracranial Hemorrhage
Status: Enrolling
Updated: 1/23/2018
University of Cincinnati Medical Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Robotic and Conventional Hand Therapy After Stroke
Robot-assisted Hand Training (Amadeo) Compared With Conventional Physiotherapy Techniques in Chronic Ischemic Stroke Patients: A Pilot Study
Status: Enrolling
Updated:  1/23/2018
Columbia University Medical Center
mi
from
New York, NY
Robotic and Conventional Hand Therapy After Stroke
Robot-assisted Hand Training (Amadeo) Compared With Conventional Physiotherapy Techniques in Chronic Ischemic Stroke Patients: A Pilot Study
Status: Enrolling
Updated: 1/23/2018
Columbia University Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Robotic and Conventional Hand Therapy After Stroke
Robot-assisted Hand Training (Amadeo) Compared With Conventional Physiotherapy Techniques in Chronic Ischemic Stroke Patients: A Pilot Study
Status: Enrolling
Updated:  1/23/2018
Innsbruck Medical University
mi
from
Innsbruck,
Robotic and Conventional Hand Therapy After Stroke
Robot-assisted Hand Training (Amadeo) Compared With Conventional Physiotherapy Techniques in Chronic Ischemic Stroke Patients: A Pilot Study
Status: Enrolling
Updated: 1/23/2018
Innsbruck Medical University
mi
from
Innsbruck,
Click here to add this to my saved trials
Trial of RAD001 and Neurocognition in Tuberous Sclerosis Complex (TSC)
Randomized Double-Blind Phase 2 Trial Of RAD001 For Neurocognition In Individuals With Tuberous Sclerosis Complex
Status: Enrolling
Updated:  1/24/2018
Boston Children's Hospital
mi
from
Boston, MA
Trial of RAD001 and Neurocognition in Tuberous Sclerosis Complex (TSC)
Randomized Double-Blind Phase 2 Trial Of RAD001 For Neurocognition In Individuals With Tuberous Sclerosis Complex
Status: Enrolling
Updated: 1/24/2018
Boston Children's Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Trial of RAD001 and Neurocognition in Tuberous Sclerosis Complex (TSC)
Randomized Double-Blind Phase 2 Trial Of RAD001 For Neurocognition In Individuals With Tuberous Sclerosis Complex
Status: Enrolling
Updated:  1/24/2018
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Trial of RAD001 and Neurocognition in Tuberous Sclerosis Complex (TSC)
Randomized Double-Blind Phase 2 Trial Of RAD001 For Neurocognition In Individuals With Tuberous Sclerosis Complex
Status: Enrolling
Updated: 1/24/2018
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Phase 1/2 Study of Vorinostat Therapy in Niemann-Pick Disease, Type C1
Phase 1/2 Study of Vorinostat Therapy in Niemann-Pick Disease, Type C1
Status: Enrolling
Updated:  1/24/2018
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Phase 1/2 Study of Vorinostat Therapy in Niemann-Pick Disease, Type C1
Phase 1/2 Study of Vorinostat Therapy in Niemann-Pick Disease, Type C1
Status: Enrolling
Updated: 1/24/2018
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
High Definition Cathodal Transcranial Direct Current Stimulation for Treatment of Refractory Partial Onset Epilepsy
High Definition Cathodal Transcranial Direct Current Stimulation for Treatment of Refractory Partial Onset Epilepsy
Status: Enrolling
Updated:  1/24/2018
Boston Children's Hospital - Neurology
mi
from
Boston, MA
High Definition Cathodal Transcranial Direct Current Stimulation for Treatment of Refractory Partial Onset Epilepsy
High Definition Cathodal Transcranial Direct Current Stimulation for Treatment of Refractory Partial Onset Epilepsy
Status: Enrolling
Updated: 1/24/2018
Boston Children's Hospital - Neurology
mi
from
Boston, MA
Click here to add this to my saved trials
High Definition Cathodal Transcranial Direct Current Stimulation for Treatment of Refractory Partial Onset Epilepsy
High Definition Cathodal Transcranial Direct Current Stimulation for Treatment of Refractory Partial Onset Epilepsy
Status: Enrolling
Updated:  1/24/2018
Neurology
mi
from
New York, NY
High Definition Cathodal Transcranial Direct Current Stimulation for Treatment of Refractory Partial Onset Epilepsy
High Definition Cathodal Transcranial Direct Current Stimulation for Treatment of Refractory Partial Onset Epilepsy
Status: Enrolling
Updated: 1/24/2018
Neurology
mi
from
New York, NY
Click here to add this to my saved trials
Enhance Balance and Mobility in People With Type 2 Diabetic Peripheral Neuropathy
High Intensity Muscle Power and Balance Perturbation Training to Enhance Balance and Mobility in People With Type 2 Diabetic Peripheral Neuropathy
Status: Enrolling
Updated:  1/24/2018
PTRS Research Lab
mi
from
Baltimore, MD
Enhance Balance and Mobility in People With Type 2 Diabetic Peripheral Neuropathy
High Intensity Muscle Power and Balance Perturbation Training to Enhance Balance and Mobility in People With Type 2 Diabetic Peripheral Neuropathy
Status: Enrolling
Updated: 1/24/2018
PTRS Research Lab
mi
from
Baltimore, MD
Click here to add this to my saved trials
Enhance Balance and Mobility in People With Type 2 Diabetic Peripheral Neuropathy
High Intensity Muscle Power and Balance Perturbation Training to Enhance Balance and Mobility in People With Type 2 Diabetic Peripheral Neuropathy
Status: Enrolling
Updated:  1/24/2018
VA Maryland Health Care System
mi
from
Baltimore, MD
Enhance Balance and Mobility in People With Type 2 Diabetic Peripheral Neuropathy
High Intensity Muscle Power and Balance Perturbation Training to Enhance Balance and Mobility in People With Type 2 Diabetic Peripheral Neuropathy
Status: Enrolling
Updated: 1/24/2018
VA Maryland Health Care System
mi
from
Baltimore, MD
Click here to add this to my saved trials
Rebif Advanced Magnetic Resonance Imaging (MRI) and Immunology Pilot Trial
A Twenty-four Week, Two Arm, Pilot Trial to Evaluate Remyelination/ Demyelination, Gray Matter Volume and Iron Deposition in the Central Nervous System (CNS) and Immune Status of Subjects With Relapsing-remitting Multiple Sclerosis (RRMS) Treated With Rebif® 44 mcg Subcutaneously (sc) Three Times a Week (Tiw) Compared to a Healthy Control Group
Status: Enrolling
Updated:  1/25/2018
EMD Serono, Inc.
mi
from
Rockland, MA
Rebif Advanced Magnetic Resonance Imaging (MRI) and Immunology Pilot Trial
A Twenty-four Week, Two Arm, Pilot Trial to Evaluate Remyelination/ Demyelination, Gray Matter Volume and Iron Deposition in the Central Nervous System (CNS) and Immune Status of Subjects With Relapsing-remitting Multiple Sclerosis (RRMS) Treated With Rebif® 44 mcg Subcutaneously (sc) Three Times a Week (Tiw) Compared to a Healthy Control Group
Status: Enrolling
Updated: 1/25/2018
EMD Serono, Inc.
mi
from
Rockland, MA
Click here to add this to my saved trials
Treatment of Overweight Induced by Antipsychotic Medication in Young People With Autism Spectrum Disorders (ASD)
Treatment of Overweight Induced by Antipsychotic Medication in Young People With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated:  1/25/2018
Ohio State University/Nationwide Children's Hospital
mi
from
Columbus, OH
Treatment of Overweight Induced by Antipsychotic Medication in Young People With Autism Spectrum Disorders (ASD)
Treatment of Overweight Induced by Antipsychotic Medication in Young People With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated: 1/25/2018
Ohio State University/Nationwide Children's Hospital
mi
from
Columbus, OH
Click here to add this to my saved trials
Treatment of Overweight Induced by Antipsychotic Medication in Young People With Autism Spectrum Disorders (ASD)
Treatment of Overweight Induced by Antipsychotic Medication in Young People With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated:  1/25/2018
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Treatment of Overweight Induced by Antipsychotic Medication in Young People With Autism Spectrum Disorders (ASD)
Treatment of Overweight Induced by Antipsychotic Medication in Young People With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated: 1/25/2018
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Treatment of Overweight Induced by Antipsychotic Medication in Young People With Autism Spectrum Disorders (ASD)
Treatment of Overweight Induced by Antipsychotic Medication in Young People With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated:  1/25/2018
Vanderbilt University
mi
from
Nashville, TN
Treatment of Overweight Induced by Antipsychotic Medication in Young People With Autism Spectrum Disorders (ASD)
Treatment of Overweight Induced by Antipsychotic Medication in Young People With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated: 1/25/2018
Vanderbilt University
mi
from
Nashville, TN
Click here to add this to my saved trials
Treatment of Overweight Induced by Antipsychotic Medication in Young People With Autism Spectrum Disorders (ASD)
Treatment of Overweight Induced by Antipsychotic Medication in Young People With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated:  1/25/2018
Holland Bloorview Kids Rehabilitation Hospital
mi
from
Toronto,
Treatment of Overweight Induced by Antipsychotic Medication in Young People With Autism Spectrum Disorders (ASD)
Treatment of Overweight Induced by Antipsychotic Medication in Young People With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated: 1/25/2018
Holland Bloorview Kids Rehabilitation Hospital
mi
from
Toronto,
Click here to add this to my saved trials
Study to Determine the Impact of Intraoperative Blood Pressure Management on Postoperative Outcomes (MAP-ALIVE)
Mean Arterial Pressure Alert Level Impact on Vital Endpoint: the MAP-ALIVE Study
Status: Enrolling
Updated:  1/25/2018
University of Michigan School of Medicine
mi
from
Ann Arbor, MI
Study to Determine the Impact of Intraoperative Blood Pressure Management on Postoperative Outcomes (MAP-ALIVE)
Mean Arterial Pressure Alert Level Impact on Vital Endpoint: the MAP-ALIVE Study
Status: Enrolling
Updated: 1/25/2018
University of Michigan School of Medicine
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Study to Determine the Impact of Intraoperative Blood Pressure Management on Postoperative Outcomes (MAP-ALIVE)
Mean Arterial Pressure Alert Level Impact on Vital Endpoint: the MAP-ALIVE Study
Status: Enrolling
Updated:  1/25/2018
Washington University School of Medicine
mi
from
Saint Louis, MO
Study to Determine the Impact of Intraoperative Blood Pressure Management on Postoperative Outcomes (MAP-ALIVE)
Mean Arterial Pressure Alert Level Impact on Vital Endpoint: the MAP-ALIVE Study
Status: Enrolling
Updated: 1/25/2018
Washington University School of Medicine
mi
from
Saint Louis, MO
Click here to add this to my saved trials